Woo Sang Myung, Ryu Ji Kon, Lee Sang Hyub, Yoo Ji Won, Park Joo Kyung, Kim Yong-Tae, Jang Jin-Young, Kim Sun-Whe, Kang Gyeong Hoon, Yoon Yong Bum
Department of Internal Medicine, Liver Research Institute, Seoul National University College of Medicine, 28 Yeongeon-dong, Jongno-gu, Seoul, Korea (ROK).
Ann Surg Oncol. 2007 Nov;14(11):3195-201. doi: 10.1245/s10434-007-9537-y. Epub 2007 Aug 19.
Ampullary carcinoma is often considered to have a better prognosis than distal extrahepatic cholangiocarcinoma. However, studies that directly compare the recurrence and histopathological features between the two groups are rare.
Clinicopathologic factors and the long-term outcomes of 163 patients with ampullary carcinoma after radical resection were retrospectively evaluated and compared with those of 91 patients with distal extrahepatic cholangiocarcinoma.
Among the 163 ampullary carcinomas, T1 stage, well-differentiated tumors and perineural invasion were 45 (28%), 73 (45%), and 23 (14%), respectively, whereas, only five (6%) were T1 stage, 15 (17%) were well differentiated, and 63 (69%) showed perineural invasion (p < 0.001, for all) in distal extrahepatic cholangiocarcinomas. More patients with distal extrahepatic cholangiocarcinoma had liver metastasis than ampullary carcinoma (24% vs. 10%, p = 0.004). Multivariate analysis identified venous invasion and perineural invasion as risk factors for recurrence of ampullary carcinoma after radical resection. Only lymph node involvement was identified as a risk factor for recurrence of distal extrahepatic cholangiocarcinoma by multivariate analysis. Overall five-year survival of patients with ampullary cancer was higher than that of patients with distal extrahepatic cholangiocarcinoma (68% vs. 54%; p = 0.033). In patients without lymph node metastasis, a significant difference in survival was also observed between the two groups (p = 0.049).
Earlier diagnosis and the less frequent occurrence of pathological factors associated with tumor invasiveness in ampullary carcinoma than in distal extrahepatic cholangiocarcinoma may explain its association with a better prognosis.
壶腹癌通常被认为比肝外胆管远端癌预后更好。然而,直接比较两组复发情况和组织病理学特征的研究较少。
回顾性评估163例行根治性切除的壶腹癌患者的临床病理因素和长期预后,并与91例肝外胆管远端癌患者进行比较。
163例壶腹癌中,T1期、高分化肿瘤和神经周围浸润分别为45例(28%)、73例(45%)和23例(14%),而在肝外胆管远端癌中,仅5例(6%)为T1期,15例(17%)为高分化,63例(69%)有神经周围浸润(所有p值均<0.001)。肝外胆管远端癌发生肝转移的患者比壶腹癌更多(24%对10%,p = 0.004)。多因素分析确定静脉侵犯和神经周围浸润是壶腹癌根治性切除术后复发的危险因素。多因素分析仅确定淋巴结受累是肝外胆管远端癌复发的危险因素。壶腹癌患者的总体五年生存率高于肝外胆管远端癌患者(68%对54%;p = 0.033)。在无淋巴结转移的患者中,两组间生存率也存在显著差异(p = 0.049)。
与肝外胆管远端癌相比,壶腹癌更早的诊断以及与肿瘤侵袭性相关的病理因素发生率较低,可能解释了其预后较好的原因。